Drugs / Xiaojin Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07340177 | Mar 2026 → Jun 2027 expected | thyroid gland disorder | Zhejiang Provincial People's Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiaojin Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07340177 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese patent medicine” NCT07340177 ↗ |
| Route | Oral | “administered orally” NCT07340177 ↗ |